ETLI.DE vs. IROB.DE
ETLI.DE (L&G Pharma Breakthrough UCITS ETF) and IROB.DE (L&G ROBO Global Robotics and Automation UCITS ETF) are both exchange-traded funds - ETLI.DE is a Health & Biotech Equities fund tracking the Solactive Pharma Breakthrough Value, while IROB.DE is a Technology Equities fund tracking the ROBO-STOX® Global Robotics and Automation. Both are passively managed. Over the past 5 years, ETLI.DE returned 2.31%/yr vs 7.96%/yr for IROB.DE. A 0.57 correlation means they provide meaningful diversification when combined. ETLI.DE charges 0.49%/yr vs 0.80%/yr for IROB.DE.
Performance
ETLI.DE vs. IROB.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETLI.DE achieves a -0.74% return, which is significantly lower than IROB.DE's 28.27% return.
ETLI.DE
- 1D
- 2.62%
- 1M
- -3.54%
- YTD
- -0.74%
- 6M
- -2.98%
- 1Y
- 21.87%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
IROB.DE
- 1D
- -1.49%
- 1M
- 8.26%
- YTD
- 28.27%
- 6M
- 26.53%
- 1Y
- 54.17%
- 3Y*
- 13.62%
- 5Y*
- 7.96%
- 10Y*
- 13.49%
ETLI.DE vs. IROB.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 17.53% | -4.78% |
IROB.DE L&G ROBO Global Robotics and Automation UCITS ETF | 28.27% | 10.23% | 4.18% | 20.94% | -30.08% | 26.20% | 31.63% | 33.76% | -18.33% |
Correlation
The correlation between ETLI.DE and IROB.DE is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.44 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 2018 | 0.57 |
The correlation between ETLI.DE and IROB.DE shifts across timeframes, from 0.44 (1 year) to 0.57 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETLI.DE vs. IROB.DE — Risk / Return Rank
ETLI.DE
IROB.DE
ETLI.DE vs. IROB.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and L&G ROBO Global Robotics and Automation UCITS ETF (IROB.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETLI.DE | IROB.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.32 | ||
| Sortino ratioReturn per unit of downside risk | -1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.42 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.40 | 3.94 | -1.54 |
| Martin ratioReturn relative to average drawdown | 6.79 | 15.02 | -8.23 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ETLI.DE | IROB.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 2.48 | -1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | 0.37 | -0.24 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.64 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.57 | -0.35 |
Drawdowns
ETLI.DE vs. IROB.DE - Drawdown Comparison
The maximum ETLI.DE drawdown since its inception was -30.83%, smaller than the maximum IROB.DE drawdown of -36.52%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and IROB.DE.
Loading charts...
Drawdown Indicators
| ETLI.DE | IROB.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.83% | -36.52% | +5.69% |
Max Drawdown (1Y)Largest decline over 1 year | -9.06% | -13.67% | +4.61% |
Max Drawdown (3Y)Largest decline over 3 years | -24.43% | -31.95% | +7.52% |
Max Drawdown (5Y)Largest decline over 5 years | -30.83% | -36.52% | +5.69% |
Max Drawdown (10Y)Largest decline over 10 years | — | -36.52% | — |
Current DrawdownCurrent decline from peak | -4.86% | -1.77% | -3.09% |
Average DrawdownAverage peak-to-trough decline | -10.22% | -11.47% | +1.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.21% | 3.60% | -0.39% |
Volatility
ETLI.DE vs. IROB.DE - Volatility Comparison
The current volatility for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) is 6.89%, while L&G ROBO Global Robotics and Automation UCITS ETF (IROB.DE) has a volatility of 7.52%. This indicates that ETLI.DE experiences smaller price fluctuations and is considered to be less risky than IROB.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETLI.DE | IROB.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 7.52% | -0.63% |
Volatility (6M)Calculated over the trailing 6-month period | 14.09% | 16.66% | -2.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.72% | 21.72% | -3.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.22% | 21.13% | -3.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.91% | 21.01% | -2.10% |
ETLI.DE vs. IROB.DE - Expense Ratio Comparison
ETLI.DE has a 0.49% expense ratio, which is lower than IROB.DE's 0.80% expense ratio.
Dividends
ETLI.DE vs. IROB.DE - Dividend Comparison
Neither ETLI.DE nor IROB.DE has paid dividends to shareholders.
Frequently Asked Questions
ETLI.DE and IROB.DE have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, ETLI.DE is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.
ETLI.DE is cheaper with a 0.49% expense ratio, compared with 0.80% for IROB.DE.
ETLI.DE is categorized as Health & Biotech Equities, while IROB.DE is Technology Equities. ETLI.DE tracks Solactive Pharma Breakthrough Value, while IROB.DE tracks ROBO-STOX® Global Robotics and Automation. Their fees differ too: 0.49% for ETLI.DE and 0.80% for IROB.DE.
Find the right allocation for ETLI.DE and IROB.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer